Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.83B | $2.85B | -0.91% |
Gross Profit | $1.69B | $1.69B | -0.20% |
Net Income | $610.84M | $603.98M | +1.13% |
EPS (Basic) | $28.69 | $27.54 | +4.18% |
EPS (Diluted) | $28.55 | $27.37 | +4.31% |
R&D Expense | $139.3M | $138.85M | +0.33% |
SG&A Expense | $698.96M | $680.68M | +2.69% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.32B | $3.29B | +0.95% |
Current Assets | $1.2B | $1.2B | +0.11% |
Total Liabilities | $3.47B | $3.39B | +2.34% |
Current Liabilities | $1.18B | $1.07B | +10.70% |
Stockholders' Equity | $-154.35M | $-105.87M | -45.79% |
Cash & Equivalents | $71.57M | $69.67M | +2.73% |
Long-Term Debt | $1.89B | $1.93B | -1.96% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $702.16M | $684.37M | +2.60% |
Investing Cash Flow | $-68.41M | $-96.19M | +28.88% |
Financing Cash Flow | $-632.28M | $-610.61M | -3.55% |
Share Buybacks | $637.5M | $724M | -11.95% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.6% | 59.2% | +0.43% |
Net Margin | 21.6% | — | — |
ROE | -395.7% | — | — |
ROA | 18.4% | — | — |
Current Ratio | $1.011 | — | — |
Debt to Equity | $-22.508 | — | — |
Other companies in Life Sciences Tools & Services